Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management.

Clin Appl Thromb Hemost · 2020 · PMC7476343 · PMID 32877229

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

114 Another study is the Comparison of Acute Treatments in Cancer Haemostasis (CATCH) trial that compared LMWH (tinzaparin) to warfarin and showed a trend toward reduction in VTE recurrence, but the difference was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.